These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16393463)

  • 1. Effects of Transcutol P on the corneal permeability of drugs and evaluation of its ocular irritation of rabbit eyes.
    Liu Z; Li J; Nie S; Guo H; Pan W
    J Pharm Pharmacol; 2006 Jan; 58(1):45-50. PubMed ID: 16393463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Pharmasolve corneal permeability enhancement and its irritation on rabbit eyes.
    Li X; Pan W; Ju C; Liu Z; Pan H; Zhang H; Nie S
    Drug Deliv; 2009 May; 16(4):224-9. PubMed ID: 19514982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Labrasol on the corneal drug delivery of baicalin.
    Liu Z; Zhang X; Li J; Liu R; Shu L; Jin J
    Drug Deliv; 2009 Oct; 16(7):399-404. PubMed ID: 19630479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oleic acid on the corneal permeability of compounds and evaluation of its ocular irritation of rabbit eyes.
    Gao XC; Qi HP; Bai JH; Huang L; Cui H
    Curr Eye Res; 2014 Dec; 39(12):1161-8. PubMed ID: 24749683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confocal microscopic characterization of initial corneal changes of surfactant-induced eye irritation in the rabbit.
    Maurer JK; Li HF; Petroll WM; Parker RD; Cavanagh HD; Jester JV
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):291-300. PubMed ID: 9144446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Area and depth of surfactant-induced corneal injury predicts extent of subsequent ocular responses.
    Jester JV; Petroll WM; Bean J; Parker RD; Carr GJ; Cavanagh HD; Maurer JK
    Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2610-25. PubMed ID: 9856771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers.
    Li X; Nie SF; Kong J; Li N; Ju CY; Pan WS
    Int J Pharm; 2008 Nov; 363(1-2):177-82. PubMed ID: 18706987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery.
    Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G
    J Drug Target; 2011 Jul; 19(6):409-17. PubMed ID: 20678034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ocular penetration of levofloxacin 1.5% and gatifloxacin 0.3% ophthalmic solutions in subjects undergoing corneal transplant surgery.
    Holland EJ; McCarthy M; Holland S
    Curr Med Res Opin; 2007 Dec; 23(12):2955-60. PubMed ID: 17939882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of three penetration enhancers on corneal permeability of mangiferin in vitro].
    Liu R; Liu Z; Shu L; Zhang C; Zhang B
    Zhongguo Zhong Yao Za Zhi; 2010 Dec; 35(23):3131-5. PubMed ID: 21355232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative measurement of acute corneal injury in rabbits with surfactants of different type and irritancy.
    Maurer JK; Parker RD; Petroll WM; Carr GJ; Cavanagh HD; Jester JV
    Toxicol Appl Pharmacol; 1999 Jul; 158(1):61-70. PubMed ID: 10387933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular delivery of cyclosporine A based on glyceryl monooleate/poloxamer 407 liquid crystalline nanoparticles: preparation, characterization, in vitro corneal penetration and ocular irritation.
    Chen Y; Lu Y; Zhong Y; Wang Q; Wu W; Gao S
    J Drug Target; 2012 Dec; 20(10):856-63. PubMed ID: 23050903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diclofenac/biodegradable polymer micelles for ocular applications.
    Li X; Zhang Z; Li J; Sun S; Weng Y; Chen H
    Nanoscale; 2012 Aug; 4(15):4667-73. PubMed ID: 22732776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of eye irritation potential of surfactant-based rinse-off personal care formulations by the bovine corneal opacity and permeability (BCOP) assay.
    Cater KC; Harbell JW
    Cutan Ocul Toxicol; 2006; 25(3):217-33. PubMed ID: 16980247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathology of ocular irritation with bleaching agents in the rabbit low-volume eye test.
    Maurer JK; Molai A; Parker RD; Li L; Carr GJ; Petroll WM; Cavanagh HD; Jester JV
    Toxicol Pathol; 2001; 29(3):308-19. PubMed ID: 11442017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the relationship between cornea permeability and eye irritation using membrane-interaction QSAR analysis.
    Li Y; Liu J; Pan D; Hopfinger AJ
    Toxicol Sci; 2005 Dec; 88(2):434-46. PubMed ID: 16162848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of corneal and aqueous humor penetration of moxifloxacin, gatifloxacin and levofloxacin during keratoplasty.
    Fukuda M; Yamada M; Kinoshita S; Inatomi T; Ohashi Y; Uno T; Shimazaki J; Satake Y; Maeda N; Hori Y; Nishida K; Kubota A; Nakazawa T; Shimomura Y
    Adv Ther; 2012 Apr; 29(4):339-49. PubMed ID: 22529026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Part II: Enhancement of transcorneal delivery of gatifloxacin by solid lipid nanoparticles in comparison to commercial aqueous eye drops.
    Abul Kalam M; Sultana Y; Ali A; Aqil M; Mishra AK; Chuttani K; Aljuffali IA; Alshamsan A
    J Biomed Mater Res A; 2013 Jun; 101(6):1828-36. PubMed ID: 23184654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of the corneal epithelium on the intraocular penetration of fluoroquinolone ophthalmic solution.
    Fukuda M; Inoue A; Sasaki K; Takahashi N
    Jpn J Ophthalmol; 2004; 48(2):93-6. PubMed ID: 15060787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Porcine Corneal Ocular Reversibility Assay (PorCORA) predicts ocular damage and recovery for global regulatory agency hazard categories.
    Piehl M; Carathers M; Soda R; Cerven D; DeGeorge G
    Toxicol In Vitro; 2011 Dec; 25(8):1912-8. PubMed ID: 21708243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.